Empiric Therapy of Infections in Hematologic Malignancies: A Prospective, Randomized Trial

Gian Luigi Cetto, G. Perona(University of Verona), Fabrizio Vinante(University of Verona), Fabio Benini(University of Verona), Giacomo Caramaschi, Giuseppe Todeschini(University of Pisa)

Tumori Journal

April 1, 1983

10.1177/030089168306900212

Cited by 4

Related Papers

ALK+ lymphoma: clinico-pathological findings and outcome.

|PubMed|1999|569

IFNα-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

|Blood|2004|159

<i>Pneumocystis carinii</i> pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres

|British Journal of Haematology|2002|149

Transbronchial Biopsy in the Diagnosis of Pulmonary Infiltrates in Immunocompromised Patients

|CHEST Journal|1995|118

Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients

|Oncotarget|2016|89